Clinical trial
Org 24448 to Treat Major Depression
NCT00113022 · National Institute of Mental Health (NIMH), NIH · Terminated
Key facts
| NCT number | NCT00113022 |
|---|---|
| Title | Org 24448 to Treat Major Depression |
| Official title | An Investigation of the Antidepressant Efficacy and Safety of an AMPAkine (Org 24448) in Major Depressive Disorder, A Double-Blind, Placebo-Controlled, Randomized Study |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Org 24448, Placebo |
| Enrollment | 9 |
| Start date | May 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jun 3, 2005 |
| Last update posted | Jul 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: